British journal of haematology
Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre.
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Charalampos Filippatos, Vasiliki Spiliopoulou, Magdalini Migkou, Foteini Theodorakakou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Eirini Katodritou, Emmanouil Spanoudakis, Panagiotis Tsirigotis, Nikolaos Giannakoulas, Sosanna Delimpasi
Published: 202610.1111/bjh.70342
Abstract
Waldenström's macroglobulinaemia (WM) is a rare B-cell lymphoproliferative disorder with multiple effective front-line treatment options. However, real-world comparative data on commonly used regimens are limited. We conducted a retrospective cohort…
Preview only. Read the full abstract at the source